This federal contract award, with the ID SPE2DB20D9135|SPE2DB25FZV85, was issued by the Defense Logistics Agency (DLA) to the prime contractor DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of NUPLAZID 34 MG CAPSULE 30S, a specialized pharmaceutical product, with a ceiling value of $3,364.50 and a period of performance through December 12, 2024.
The contract is structured as a firm fixed-price delivery order and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide.
DMS Pharmaceutical Group Inc. also holds a significant single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a wide array of pharmaceutical products, positioning DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain.
Generated 2/19/25, 9:26 AM